Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary F Mulcahy, MD
Northwestern University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
131 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical University of Vienna
Vienna, Austria
- Onze-Lieve-Vrouwziekenuis Vzw Campus Aalst
Aalst, Belgium
- Az - Sint Lucas
Ghent, Belgium
- Universitair Ziekenhuis Gent
Ghent, Belgium
- Az Groeninge
Kortrijk, Belgium
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Qeii Health Services Center, Halifax Infirmary Site
Halifax, Nova Scotia, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- University Health Network , Mount Sinai Hospital
Toronto, Ontario, Canada
- Mcgill University Health Center - Glen Site
Montreal, Quebec, Quebec, Canada
- Royal University Hospital
Saskatoon, Saskatchewan, Canada
- Hong Kong Sanatorium Hospital
Hong Kong, China
- Queen Mary Hospital
Hong Kong, China
- Chru Montpellier - Hopital St Eloi
Montpellier, Cedex 5, France
- Cuh D'Angers
Angers, Cedex 9, France
- Chu Toulouse, Hôpital Rangueil
Toulouse, Cedex 9, France
- Institut Bergognié
Bordeaux, France
- Hôpital Beaujon
Clichy, France
- Hôpital Henri Mondor
Créteil, France
- Centre Georges Francois Leclerc
Dijon, France
- Centre Hospitalier Lyon-Sud
Lyon, France
- Hôpital la Timone
Marseille, France
- Chu Nantes-Hôtel Dieu
Nantes, France
- Chu de Nice,, Hopital Archet 2 - Service D'Imagerie Médicale Niveau -2
Nice, France
- Chu Bordeaux
Pessac, France
- Hôpital la Milétrie, Chu Poitiers, Hépato Gastroenterologie
Poitiers, France
- Centre Eugene Marquis
Rennes, France
- Universitätsklinikum Bonn
Bonn, Germany
- Universitätsklinikum Essen
Essen, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- Slk Kliniken, Heilbronn Gmbh
Heilbronn, Germany
- Universitätsklinikum Des Saarlandes
Homburg, Germany
- University Hospital of Leipzig
Leipzig, Germany
- Universitaetsklinikum Marburg Klinik Für Dermatologie Und Allergologie
Marburg, Germany
- Eberhard-Karls-University Tübingen
Tübingen, Germany
- Azienda Ospedaliera-Universitaria, Policlinico Sant'Orsola Malpighi
Bologna, Italy
- Białostockie Centrum Onkologii
Bialystok, Poland
- Centrum Onkologii - Instytut, Im. Marii Skłodowskiej-Curie
Gliwice, Poland
- Regionalny Szpital Specjalistyczny Im. Dr Władysława Biegańskiego
Grudziądz, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2012
- Primary completion
- 31 Aug 2020
- Completion
- 31 Aug 2020
- Last update posted
- 29 Mar 2022
- Registered enrollment
- 428
- Registry id
- NCT01483027
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.